Study uncovers mechanism by which tumor suppressor MIG6 triggers cell suicide
Image depicts a cross section of a Mig6 mutant mammary duct showing the over proliferating epithelial cells. Credit: Ludwig Institute of Cancer Research, Uppsala University, Sweden
Death plays a big role in keeping things alive. Consider the tightly orchestrated suicide of cells—a phenomenon essential to everything from shaping an embryo to keeping it free of cancer later in life. When cells refuse to die, and instead multiply uncontrollably, they become what we call tumors. An intricate circuitry of biochemical reactions inside cells coordinates their self-sacrifice. Tracing that circuitry is, naturally, an important part of cancer research.
In a major contribution to that effort Dr. Ingvar Ferby, a Ludwig researcher based at Uppsala University in Sweden, led a team of researchers who have determined the outsize role a small protein named Mig6 plays in such processes. Their findings, reported online in the September 11 issue of Developmental Cell, unveil a conceptually novel mechanism for the biological regulation of cell suicide.
The studies focus on epithelial tissue in the mammary glands of mice. Though diverse in function, such epithelial linings—found on the surfaces of virtually every organ and gland in the body—generally consist of a stack of functionally distinct cells layered over a membrane that acts like a floor. The outermost cells of epithelia constantly die, slough off and are replaced. This tightly regulated process is known as epithelial homeostasis; where it breaks down, tumors often ensue.
To figure out what exactly Mig6 does, Ferby and his colleagues studied what happens in the mammary glands of mice engineered to lack the gene for that protein. His laboratory had previously shown that such mice tend to spontaneously develop tumors—suggesting that Mig6 somehow suppresses cancer. In the current study, he and his team noticed that tiny ducts in the mammary glands of these mice were clogged with aberrantly proliferating epithelial cells.
The question was why. To find out, Ferby's team took epithelial cells from mutant mice and their normal littermates and used them to conduct an elegant series of experiments. They discovered that Mig6 is the chief instigator of suicide in these cells.
Mig6 was already known to dampen the signal of a secreted protein named epidermal growth factor (EGF) by binding to its receptor, and EGF plays an important role in maintaining epithelial homeostasis. But Ferby and his colleagues discovered that Mig6 really kicks into gear only after EGF is taken away. It drops off the EGF receptor and promptly latches on to an intracellular protein named cAbl. This activates cAbl, initiating a signaling cascade that reaches into the nucleus and turns on a key enzyme involved in cell suicide.
They next asked what keeps Mig6 from triggering cell death in the presence of EGF?
The answer, it seems, is yet another protein, Src, which is known to be activated by the EGF receptor. Ferby and his colleagues found that Src chemically modifies cAbl in a manner that prohibits its activation by Mig6. Conversely, when EGF is removed and its receptor becomes dormant, Src gets shut down—allowing Mig6 and cAbl to work together to induce cell suicide.
"In other words," explains Sarah Hopkins, a post-doctoral researcher at UCL (University College London) and the lead author of the study, "Mig6 is an intracellular sensor that detects the absence of a proliferative signal, such as EGF, and, in response, induces normal cell death."
Mig6 keeps the growth of epithelial cells dependent on EGF. This is notable because escape from such dependence is an early step in the generation of some tumors. Mig6 is known to be silenced in many human epithelial cancers, including those of the lung, pancreas, breast and skin.
"The findings from this study may have an impact on how we evaluate drugs that inhibit cAbl," says Ferby. "These therapies are designed to target a mutated version of cAbl that promotes cancer. But by disabling healthy cAbl, they may well interfere with a protein essential to Mig6's work inside the cell."
And that work, as these findings suggest, is clearly very important.
More information: 'Mig6 is a sensor of EGR receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis,' Sarah Hopkins, Emma Linderoth, Oliver Hantschel, Paula Surarez-Henriques, Giulia Pilia, Howard Kendrick, Matthew J. Smalley, Giulio Superti-Furga, Ingvar Ferby, Developmental Cell, online publication 11 September 2012.
Journal reference: Developmental Cell
Provided by Ludwig Institute for Cancer Research
- Rogue receptor opens door for rare kidney disease Sep 25, 2011 | not rated yet | 0
- Protein that promotes cancer cell growth identified Jul 24, 2009 | not rated yet | 0
- Signaling pathways point to vulnerability in breast cancer stem cells Jun 09, 2011 | not rated yet | 0
- Researchers identify new protein that triggers breast cancer Jan 14, 2009 | not rated yet | 0
- Researchers discover protein that contributes to cancer spread Dec 08, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
7 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
Cancer 1 hour ago | 5 / 5 (1) | 0
For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...
Cancer 2 hours ago | 5 / 5 (1) | 0 |
More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report1 from Cancer Research UK.
Cancer 2 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...
Cancer 3 hours ago | 3.5 / 5 (2) | 0 |
(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.
Cancer 17 hours ago | not rated yet | 0
A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...
3 minutes ago | not rated yet | 0
Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.
1 hour ago | 5 / 5 (1) | 0 |
Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.
1 hour ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...
1 hour ago | not rated yet | 0 |
Studying the networks of connections in the brains of people affected by schizophrenia, bipolar disease or depression has allowed Dr. Peter Williamson, from Western University, to gain a better understanding of the biological ...
1 hour ago | not rated yet | 0
New techniques in imaging of brain activity developed by Jean Gotman, from McGill University's Montreal Neurological Institute, and his colleagues lead to improved treatment of patients suffering from epilepsy. The combination ...
1 hour ago | not rated yet | 0